374 related articles for article (PubMed ID: 24080104)
1. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
[TBL] [Abstract][Full Text] [Related]
2. Natural Sesquiterpene Lactones of the 4,15-
Lenz M; Krauth-Siegel RL; Schmidt TJ
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623252
[TBL] [Abstract][Full Text] [Related]
3. Validation of Trypanosoma brucei trypanothione synthetase as drug target.
Comini MA; Guerrero SA; Haile S; Menge U; Lünsdorf H; Flohé L
Free Radic Biol Med; 2004 May; 36(10):1289-302. PubMed ID: 15110394
[TBL] [Abstract][Full Text] [Related]
4. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives.
Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861
[TBL] [Abstract][Full Text] [Related]
5. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
Leroux AE; Krauth-Siegel RL
Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
[TBL] [Abstract][Full Text] [Related]
6. Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites.
Bocedi A; Dawood KF; Fabrini R; Federici G; Gradoni L; Pedersen JZ; Ricci G
FASEB J; 2010 Apr; 24(4):1035-42. PubMed ID: 19952282
[TBL] [Abstract][Full Text] [Related]
7. Effects of polyamines on two strains of Trypanosoma brucei in infected rats and in vitro culture.
Nishimura K; Yanase T; Araki N; Ohnishi Y; Kozaki S; Shima K; Asakura M; Samosomsuk W; Yamasaki S
J Parasitol; 2006 Apr; 92(2):211-7. PubMed ID: 16729674
[TBL] [Abstract][Full Text] [Related]
8. Drug target validation of the trypanothione pathway enzymes through metabolic modelling.
Olin-Sandoval V; González-Chávez Z; Berzunza-Cruz M; Martínez I; Jasso-Chávez R; Becker I; Espinoza B; Moreno-Sánchez R; Saavedra E
FEBS J; 2012 May; 279(10):1811-33. PubMed ID: 22394478
[TBL] [Abstract][Full Text] [Related]
9. Trypanothione biosynthesis in Leishmania major.
Oza SL; Shaw MP; Wyllie S; Fairlamb AH
Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome.
Ariyanayagam MR; Oza SL; Guther ML; Fairlamb AH
Biochem J; 2005 Oct; 391(Pt 2):425-32. PubMed ID: 16008527
[TBL] [Abstract][Full Text] [Related]
11. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A
J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839
[TBL] [Abstract][Full Text] [Related]
12. Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasis.
Torrie LS; Wyllie S; Spinks D; Oza SL; Thompson S; Harrison JR; Gilbert IH; Wyatt PG; Fairlamb AH; Frearson JA
J Biol Chem; 2009 Dec; 284(52):36137-36145. PubMed ID: 19828449
[TBL] [Abstract][Full Text] [Related]
13. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.
Benítez D; Medeiros A; Fiestas L; Panozzo-Zenere EA; Maiwald F; Prousis KC; Roussaki M; Calogeropoulou T; Detsi A; Jaeger T; Šarlauskas J; Peterlin Mašič L; Kunick C; Labadie GR; Flohé L; Comini MA
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004617. PubMed ID: 27070550
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated silencing of ornithine decarboxylase and spermidine synthase genes in Trypanosoma brucei provides insight into regulation of polyamine biosynthesis.
Xiao Y; McCloskey DE; Phillips MA
Eukaryot Cell; 2009 May; 8(5):747-55. PubMed ID: 19304951
[TBL] [Abstract][Full Text] [Related]
17. Gene knockdown of gamma-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme.
Huynh TT; Huynh VT; Harmon MA; Phillips MA
J Biol Chem; 2003 Oct; 278(41):39794-800. PubMed ID: 12888552
[TBL] [Abstract][Full Text] [Related]
18. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
[TBL] [Abstract][Full Text] [Related]
20. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
